Umamaheswari Ramachandran

Array ( [id] => 5952392 [patent_doc_number] => 20110033468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Ophthalmic Drug Delivery System Containing Phospholipid and Cholesterol' [patent_app_type] => utility [patent_app_number] => 12/538435 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4449 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033468.pdf [firstpage_image] =>[orig_patent_app_number] => 12538435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499542 [patent_doc_number] => 20110262485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 13/057662 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 48660 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262485.pdf [firstpage_image] =>[orig_patent_app_number] => 13057662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062243 [patent_doc_number] => 20110200624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'NOVEL PEPTIDES FOR USE IN TRANSFECTION' [patent_app_type] => utility [patent_app_number] => 13/056930 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8707 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200624.pdf [firstpage_image] =>[orig_patent_app_number] => 13056930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993827 [patent_doc_number] => 20110015374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Method for Commercial Isolation of Egg Yolk IgY, Its Product, and Uses of the Product' [patent_app_type] => utility [patent_app_number] => 12/504248 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3316 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015374.pdf [firstpage_image] =>[orig_patent_app_number] => 12504248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484620 [patent_doc_number] => 20110250237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'IMMUNOGENIC AMPHIPATHIC PEPTIDE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/003557 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 38407 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250237.pdf [firstpage_image] =>[orig_patent_app_number] => 13003557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234919 [patent_doc_number] => 20100266623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'SYNTHETIC, SELF ADJUVANTING VACCINES' [patent_app_type] => utility [patent_app_number] => 12/498983 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 16863 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266623.pdf [firstpage_image] =>[orig_patent_app_number] => 12498983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464422 [patent_doc_number] => 20090324622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'ANTIBODY VACCINE CONJUGATES AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/496719 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20078 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324622.pdf [firstpage_image] =>[orig_patent_app_number] => 12496719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586420 [patent_doc_number] => 20110280930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'PRODUCTS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/736706 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 31277 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280930.pdf [firstpage_image] =>[orig_patent_app_number] => 12736706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846433 [patent_doc_number] => 08455615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Methods and compositions for prostate cancer immunotherapy' [patent_app_type] => utility [patent_app_number] => 12/990438 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 28 [patent_no_of_words] => 19106 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228989 [patent_doc_number] => 20100183727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Immunonanotherapeutics that Provide IgG Humoral Response Without T-Cell Antigen' [patent_app_type] => utility [patent_app_number] => 12/428408 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 80925 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183727.pdf [firstpage_image] =>[orig_patent_app_number] => 12428408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669103 [patent_doc_number] => 20110318372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'INDOLEAMINE 2,3-DIOXYGENASE BASED IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 12/988124 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27076 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316679 [patent_doc_number] => 20090281277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'PEPTIDES CAPABLE OF BINDING TO SERUM PROTEINS AND COMPOUNDS, CONSTRUCTS AND POLYPEPTIDES COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/424986 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 42541 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281277.pdf [firstpage_image] =>[orig_patent_app_number] => 12424986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149055 [patent_doc_number] => 09181331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Pharmaceutical compositions for binding sphingosine-1-phosphate' [patent_app_type] => utility [patent_app_number] => 12/418597 [patent_app_country] => US [patent_app_date] => 2009-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16511 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12418597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533048 [patent_doc_number] => 20090232836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Vaccine Compositions for Inducing Immune Responses Against Components of Drusen' [patent_app_type] => utility [patent_app_number] => 12/404990 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10741 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232836.pdf [firstpage_image] =>[orig_patent_app_number] => 12404990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811450 [patent_doc_number] => 08133981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Therapeutic use of anti-CS1 antibodies' [patent_app_type] => utility [patent_app_number] => 12/401513 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 43164 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133981.pdf [firstpage_image] =>[orig_patent_app_number] => 12401513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5403513 [patent_doc_number] => 20090238827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/401531 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 43210 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238827.pdf [firstpage_image] =>[orig_patent_app_number] => 12401531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969328 [patent_doc_number] => 20110151015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING' [patent_app_type] => utility [patent_app_number] => 12/920944 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11324 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20110151015.pdf [firstpage_image] =>[orig_patent_app_number] => 12920944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552277 [patent_doc_number] => 20090286263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'SKIN TAPE STRIPPING: A NON-INVASIVE DIAGNOSTIC STRATEGY FOR DERMAL EXPOSURE TO CYTOTOXIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/398010 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10060 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286263.pdf [firstpage_image] =>[orig_patent_app_number] => 12398010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473686 [patent_doc_number] => 20090246852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/397026 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 45319 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246852.pdf [firstpage_image] =>[orig_patent_app_number] => 12397026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514216 [patent_doc_number] => 20090214522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/389140 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17247 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214522.pdf [firstpage_image] =>[orig_patent_app_number] => 12389140 [rel_patent_id] =>[rel_patent_doc_number] =>)